Humanwell Healthcare (Group) Co Ltd
600079
Company Profile
Business description
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. Being a pharmaceutical company, it provides medicinal products including fertility-regulating drugs, Uygur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
Contact
No.666 Gaoxin Road
East Lake High-tech Development Zone, Hubei
Hubei Province
Wuhan430075
CHNT: +86 2787173710
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2024
Employees
17,676
Stocks News & Analysis
stocks
The ASX healthcare player soaring to all-time highs
The steep market reaction comes after a recent announcement by the ACCC
stocks
Ask the analyst: How long is WiseTech's growth runway?
Roy Van Keulen answers my question on how big a growth opportunity remains for the ASX's biggest technology company.
video
Why the ASX's most overlooked world champion is no dinosaur
Brambles is the undisputed king of pallet pooling. Esther Holloway joined me to talk about its moat, growth prospects and risk of disruption.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,416.60 | 57.70 | -0.68% |
| CAC 40 | 7,559.46 | 81.68 | 1.09% |
| DAX 40 | 19,133.47 | 118.06 | 0.62% |
| Dow JONES (US) | 42,054.23 | 42.64 | 0.10% |
| FTSE 100 | 8,291.34 | 8.82 | 0.11% |
| HKSE | 22,736.87 | 623.36 | 2.82% |
| NASDAQ | 18,020.66 | 102.18 | 0.57% |
| Nikkei 225 | 38,635.62 | 83.56 | 0.22% |
| NZX 50 Index | 12,619.94 | 47.28 | 0.38% |
| S&P 500 | 5,715.95 | 16.01 | 0.28% |
| S&P/ASX 200 | 8,150.00 | 55.20 | -0.67% |
| SSE Composite Index | 3,336.50 | 248.97 | 8.06% |